Agenus (AGEN) Announces Extension of Cancer Antibody Collaboration with Merck (MRK)
Tweet Send to a Friend
Agenus (NASDAQ: AGEN) announced that Merck (NYSE: MRK), through a subsidiary, has extended its collaborative research term under its existing ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE